JP2018012698A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018012698A5 JP2018012698A5 JP2017145036A JP2017145036A JP2018012698A5 JP 2018012698 A5 JP2018012698 A5 JP 2018012698A5 JP 2017145036 A JP2017145036 A JP 2017145036A JP 2017145036 A JP2017145036 A JP 2017145036A JP 2018012698 A5 JP2018012698 A5 JP 2018012698A5
- Authority
- JP
- Japan
- Prior art keywords
- methods
- novel articles
- manufacture substantially
- manufacture
- articles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 claims 1
Claims (1)
- 本願明細書に実質的に記載された、新規な物、方法及び製造方法。
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8668708P | 2008-08-06 | 2008-08-06 | |
US61/086,687 | 2008-08-06 | ||
US15103609P | 2009-02-09 | 2009-02-09 | |
US61/151,036 | 2009-02-09 | ||
US17308809P | 2009-04-27 | 2009-04-27 | |
US61/173,088 | 2009-04-27 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015093417A Division JP2015157843A (ja) | 2008-08-06 | 2015-04-30 | ポリ(adp−リボース)ポリメラーゼ(parp)のジヒドロピリドフタラジノン阻害剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018012698A JP2018012698A (ja) | 2018-01-25 |
JP2018012698A5 true JP2018012698A5 (ja) | 2018-09-06 |
Family
ID=41129519
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011522113A Active JP5984389B2 (ja) | 2008-08-06 | 2009-07-27 | ポリ(adp−リボース)ポリメラーゼ(parp)のジヒドロピリドフタラジノン阻害剤 |
JP2015093417A Pending JP2015157843A (ja) | 2008-08-06 | 2015-04-30 | ポリ(adp−リボース)ポリメラーゼ(parp)のジヒドロピリドフタラジノン阻害剤 |
JP2017145036A Pending JP2018012698A (ja) | 2008-08-06 | 2017-07-27 | ポリ(adp−リボース)ポリメラーゼ(parp)のジヒドロピリドフタラジノン阻害剤 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011522113A Active JP5984389B2 (ja) | 2008-08-06 | 2009-07-27 | ポリ(adp−リボース)ポリメラーゼ(parp)のジヒドロピリドフタラジノン阻害剤 |
JP2015093417A Pending JP2015157843A (ja) | 2008-08-06 | 2015-04-30 | ポリ(adp−リボース)ポリメラーゼ(parp)のジヒドロピリドフタラジノン阻害剤 |
Country Status (31)
Country | Link |
---|---|
US (7) | US8012976B2 (ja) |
EP (3) | EP3241832A1 (ja) |
JP (3) | JP5984389B2 (ja) |
KR (1) | KR101846029B1 (ja) |
CN (3) | CN102171214B (ja) |
AR (1) | AR072970A1 (ja) |
AU (1) | AU2009279944B2 (ja) |
BR (1) | BRPI0917119B1 (ja) |
CA (1) | CA2732797C (ja) |
CY (3) | CY1115022T1 (ja) |
DK (2) | DK2326650T3 (ja) |
ES (2) | ES2625817T3 (ja) |
FR (1) | FR19C1071I2 (ja) |
GB (1) | GB2462361A (ja) |
HK (2) | HK1157755A1 (ja) |
HR (1) | HRP20170982T1 (ja) |
HU (2) | HUE035295T2 (ja) |
IL (1) | IL211070A (ja) |
LT (2) | LT2767537T (ja) |
LU (1) | LUC00140I2 (ja) |
MX (1) | MX2011001328A (ja) |
NL (1) | NL301021I2 (ja) |
NO (1) | NO2019042I1 (ja) |
NZ (1) | NZ591166A (ja) |
PL (2) | PL2326650T3 (ja) |
PT (2) | PT2326650E (ja) |
SG (2) | SG193842A1 (ja) |
SI (2) | SI2326650T1 (ja) |
TW (2) | TW201422617A (ja) |
WO (1) | WO2010017055A2 (ja) |
ZA (1) | ZA201100897B (ja) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2326650T3 (pl) | 2008-08-06 | 2014-07-31 | Biomarin Pharm Inc | Dihydropirydoftalazynonowe inhibitory polimerazy poli-(ADP-rybozy) (PARP) |
EP2376485B1 (en) | 2008-12-19 | 2017-12-06 | Vertex Pharmaceuticals Incorporated | Pyrazine derivatives useful as inhibitors of atr kinase |
CN102869258A (zh) | 2010-02-03 | 2013-01-09 | 生物马林药物股份有限公司 | 用于pten基因缺失相关疾病的治疗的聚(adp-核糖)聚合酶(parp)的二氢吡啶并酞嗪酮抑制剂 |
US20110190266A1 (en) * | 2010-02-04 | 2011-08-04 | Daniel Chu | 5,6,6a,7,8,9-HEXAHYDRO-2H-PYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) |
HUE030794T2 (en) * | 2010-02-08 | 2017-06-28 | Medivation Technologies Inc | Synthesis Processes of Dihydro-Pyrido-Phthalazinone Derivatives |
WO2011130661A1 (en) * | 2010-04-16 | 2011-10-20 | Biomarin Pharmaceutical Inc. | Methods of using dihydropyridophthalazinone inhibitors of poly (adp-ribose)polymerase (parp) |
MX2012013081A (es) | 2010-05-12 | 2013-05-09 | Vertex Pharma | Compuestos utiles como inhibidores de cinasa atr. |
TWI643858B (zh) * | 2010-10-21 | 2018-12-11 | 美商梅迪維新技術有限責任公司 | 結晶型(8S,9R)-5-氟-8-(4-氟苯基)-9-(1-甲基-1H-1,2,4-三唑-5-基)-8,9-二氫-2H-吡啶并[4,3,2-de]呔-3(7H)-酮甲苯磺酸鹽 |
WO2012166151A1 (en) * | 2011-06-03 | 2012-12-06 | Biomarin Pharmaceutical Inc. | Use of dihydropyridophthalazinone inhibitors of poly (adp-ribose) polymerase (parp) in the treatment of myelodysplastic syndrome (mds) and acute myeloid leukaemia (aml) |
WO2013028495A1 (en) * | 2011-08-19 | 2013-02-28 | Biomarin Pharmaceutical Inc. | Dihydropyridophthalazinone inhibitors of poly (adp-ribose) polymerase (parp) for the treatment of multiple myeloma |
ES2751741T3 (es) | 2011-09-30 | 2020-04-01 | Vertex Pharma | Procedimiento para fabricar compuestos útiles como inhibidores de la quinasa ATR |
MX2014003785A (es) | 2011-09-30 | 2014-07-24 | Vertex Phamaceuticals Inc | Tratamiento del cancer de pancreas y del cancer de pulmon de celulas no pequeñas con inhibidores de atr. |
SG11201401726VA (en) | 2011-12-31 | 2014-10-30 | Beigene Ltd | Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as parp inhibitors |
KR101684039B1 (ko) * | 2011-12-31 | 2016-12-07 | 베이진 엘티디 | Parp 저해제로서의 융합된 테트라 또는 펜타-사이클릭 피리도프탈라지논 |
KR20210048608A (ko) | 2012-01-20 | 2021-05-03 | 데니스 엠. 브라운 | 다형교모세포종 및 수모세포종을 비롯한 신생종양 질환 및 암 줄기세포의 치료를 위한 디안히드로갈락티톨 및 유사체를 비롯한 치환된 헥시톨의 용도 |
CA2869309C (en) | 2012-04-05 | 2021-02-09 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase and combination therapies thereof |
WO2014055756A1 (en) | 2012-10-04 | 2014-04-10 | Vertex Pharmaceuticals Incorporated | Method for measuring atr inhibition mediated increases in dna damage |
EP2918292B1 (en) | 2012-11-08 | 2019-12-11 | Nippon Kayaku Kabushiki Kaisha | Polymeric compound having camptothecin compound and anti-cancer effect enhancer bound thereto, and use of same |
CA2905751A1 (en) | 2013-03-13 | 2014-10-09 | Forma Therapeutics, Inc. | Novel compounds and compositions for inhibition of fasn |
US9993460B2 (en) | 2013-07-26 | 2018-06-12 | Race Oncology Ltd. | Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof |
CN105916846A (zh) * | 2013-11-07 | 2016-08-31 | 麦迪韦逊科技有限公司 | 用于合成经保护的n-烷基三唑甲醛的三唑中间体 |
CN103772395B (zh) * | 2014-01-23 | 2016-05-11 | 中国药科大学 | 一类具有parp抑制活性的化合物、其制备方法及用途 |
EP3125920B1 (en) | 2014-04-04 | 2020-12-23 | Del Mar Pharmaceuticals | Dianhydrogalactitol, diacetyldianhydrogalactitol or dibromodulcitol to treat non-small-cell carcinoma of the lung and ovarian cancer |
JP6936007B2 (ja) | 2014-06-17 | 2021-09-15 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | Chk1阻害剤とatr阻害剤との組み合わせを使用してがんを処置する方法 |
EP3174855B1 (en) * | 2014-07-31 | 2023-05-10 | Medivation Technologies LLC | Coformer salts of (2s,3s)-methyl 7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1h-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate and methods of preparing them |
WO2016138574A1 (en) | 2015-03-02 | 2016-09-09 | Sinai Health System | Homologous recombination factors |
WO2017003723A1 (en) | 2015-07-01 | 2017-01-05 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
AU2016312011B2 (en) | 2015-08-25 | 2021-02-04 | Beigene, Ltd. | Process for preparing Parp inhibitor, crystalline forms, and uses thereof |
AU2016331955B2 (en) | 2015-09-30 | 2022-07-21 | Vertex Pharmaceuticals Incorporated | Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors |
US9708319B1 (en) * | 2016-06-13 | 2017-07-18 | Yong Xu | Synthesis of PARP inhibitor talazoparib |
CN110087730B (zh) * | 2016-09-27 | 2023-03-28 | 百济神州(苏州)生物科技有限公司 | 使用包含parp抑制剂的组合产品治疗癌症 |
JP6541635B2 (ja) * | 2016-10-28 | 2019-07-10 | ベイジーン リミテッド | Parp阻害剤としての縮合四環式または縮合五環式ジヒドロジアゼピノカルバゾロン |
CN108210461A (zh) * | 2016-12-16 | 2018-06-29 | 中国科学院上海药物研究所 | 一种Talazoparib药物组合物及其应用 |
CN107556312B (zh) * | 2016-12-29 | 2020-04-10 | 广州丹康医药生物有限公司 | 具有parp抑制活性的新型稠环化合物、其制备方法和用途 |
WO2018122168A1 (en) | 2016-12-29 | 2018-07-05 | Bayer Pharma Aktiengesellschaft | Combinations of bub1 kinase and parp inhibitors |
CN107573341B (zh) * | 2016-12-29 | 2020-08-14 | 广州丹康医药生物有限公司 | 作为parp抑制剂的新型稠环化合物、其制备方法和应用 |
TW201840564A (zh) | 2017-02-28 | 2018-11-16 | 英屬開曼群島商百濟神州有限公司 | 稠合的四環或五環二氫二氮呯幷哢唑酮的鹽的結晶形式及其用途 |
WO2018205938A1 (zh) * | 2017-05-08 | 2018-11-15 | 广州丹康医药生物有限公司 | Parp抑制剂、其药物组合物、制备方法和应用 |
EP3658560A4 (en) | 2017-07-25 | 2021-01-06 | Crinetics Pharmaceuticals, Inc. | SOMATOSTAT IN MODULATORS AND USES THEREOF |
MX2020003361A (es) | 2017-10-13 | 2020-07-29 | Merck Patent Gmbh | Combinacion de un inhibidor parp y un antagonista de union al eje pd-1. |
TW201938165A (zh) | 2017-12-18 | 2019-10-01 | 美商輝瑞股份有限公司 | 治療癌症的方法及組合療法 |
CN110272419A (zh) * | 2018-03-14 | 2019-09-24 | 上海艾力斯医药科技有限公司 | 二氢吡啶并酞嗪酮衍生物、其制备方法及应用 |
CN108341792B (zh) * | 2018-04-28 | 2021-09-17 | 苏州莱克施德药业有限公司 | 一种Volasertib中间体1-环丙基甲基哌嗪的制备方法 |
CN108676888B (zh) * | 2018-07-12 | 2022-01-28 | 吉林大学 | 一种肺部恶性肿瘤易感性预测试剂盒及系统 |
TWI767148B (zh) | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | 抑制脂肪酸合成酶(fasn) |
WO2020092395A1 (en) | 2018-10-29 | 2020-05-07 | Forma Therapeutics, Inc. | SOLID FORMS OF (4-(2-FLUORO-4-(1-METHYL-1 H-BENZO[d]IMIDAZOL-5-YL)BENZOYL) PIPERAZIN-1-YL)(1-HYDROXYCYCLOPROPYL)METHANONE |
EP3876940A1 (en) | 2018-11-05 | 2021-09-15 | Pfizer Inc. | Combinations for treating cancer |
WO2020232119A1 (en) | 2019-05-14 | 2020-11-19 | Nuvation Bio Inc. | Anti-cancer nuclear hormone receptor-targeting compounds |
US20220227757A1 (en) | 2019-05-14 | 2022-07-21 | Suzhou Four Health Pharmaceuticals Co., Ltd. | Quinazoline-2,4-dione derivatives as parp inhibitors |
WO2021097046A1 (en) | 2019-11-13 | 2021-05-20 | Nuvation Bio Inc. | Anti-cancer nuclear hormone receptor-targeting compounds |
CN111116514B (zh) * | 2020-01-10 | 2024-03-19 | 广州科锐特生物科技有限公司 | 一种1-环丙甲酰基哌嗪盐酸盐的制备方法 |
WO2021181233A2 (en) | 2020-03-09 | 2021-09-16 | Pfizer Inc. | Fusion proteins and uses thereof |
IL302889A (en) | 2020-11-13 | 2023-07-01 | Pfizer | Gelatin capsules containing talazofrib |
WO2022123427A1 (en) | 2020-12-07 | 2022-06-16 | Pfizer Inc. | Methods of identifying a tumor that is sensitive to treatment with talazoparib and methods of treatment thereof |
TW202304928A (zh) | 2021-03-23 | 2023-02-01 | 美商諾維雪碧歐公司 | 抗癌核荷爾蒙受體標靶化合物 |
AU2022244439A1 (en) | 2021-03-24 | 2023-09-28 | Astellas Pharma Inc. | Combination of talazoparib and an anti-androgen for the treatment of ddr gene mutated metastatic castration-sensitive prostate cancer |
AU2022253474A1 (en) * | 2021-04-08 | 2023-11-16 | Board Of Regents, The University Of Texas System | Compounds and methods for theranostic targeting of parp activity |
IL308104A (en) | 2021-05-03 | 2023-12-01 | Nuvation Bio Inc | Nuclear hormone receptor-targeted compounds against cancer |
EP4089093A1 (en) * | 2021-05-12 | 2022-11-16 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Radiosynthesis of [18f] talazoparib |
WO2023131894A1 (en) | 2022-01-08 | 2023-07-13 | Pfizer Inc. | Genomic loss of heterozygosity as a predictive biomarker for treatment with talazoparib and methods of treatment thereof |
WO2023201338A1 (en) | 2022-04-15 | 2023-10-19 | Ideaya Biosciences, Inc. | Combination therapy comprising a mat2a inhibitor and a parp inhibitor |
WO2023233295A1 (en) | 2022-06-01 | 2023-12-07 | Ideaya Biosciences, Inc. | Thiadiazolyl derivatives as dna polymerase theta inhibitors and uses thereof |
WO2023239789A1 (en) * | 2022-06-08 | 2023-12-14 | Valo Health, Inc. | Tricyclic phthalazinone parp inhibitors and methods of use |
CN115572218B (zh) * | 2022-08-29 | 2024-04-16 | 江阴勒森生物科技有限公司 | 一种2-溴-3-羟基苯甲醛及其相关化学发光底物中间体的制备方法 |
WO2024074959A1 (en) | 2022-10-02 | 2024-04-11 | Pfizer Inc. | Combination of talazoparib and enzalutamide in the treatment of metastatic castration-resistant prostate cancer |
WO2024127140A1 (en) | 2022-12-17 | 2024-06-20 | Pfizer Inc. | Combination of talazoparib and enzalutamide in the treatment of metastatic castration-resistant prostate cancer |
CN116283924A (zh) * | 2023-01-16 | 2023-06-23 | 四川效佳科技有限公司 | 一种药用级纯度的苯甲酸利扎曲普坦的重结晶方法 |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US106631A (en) * | 1870-08-23 | Improvement in seed-planter | ||
US4415504A (en) | 1981-09-21 | 1983-11-15 | Tanabe Seiyaku Co., Ltd. | p-Hydroxyphenylglycine.α-phenylethanesulfonate, process for production thereof and utilization thereof in resolution of p-hydroxyphenylglycine |
JPS58225065A (ja) | 1982-06-21 | 1983-12-27 | Nippon Shinyaku Co Ltd | 2−キノロン誘導体 |
US5328905A (en) * | 1987-07-20 | 1994-07-12 | Duphar International Research B.V. | 8,9-anellated-1,2,3,4-tetrahydro-β-carboline derivatives |
CN1172502A (zh) | 1994-08-12 | 1998-02-04 | 亿万遗传股份有限公司 | 17q连锁的乳房癌和卵巢癌易患性基因的体内突变和多态性 |
WO1996005307A2 (en) | 1994-08-12 | 1996-02-22 | Myriad Genetics, Inc. | 17q-LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILITY GENE |
GB9505538D0 (en) * | 1995-03-18 | 1995-05-03 | Ciba Geigy Ag | New compounds |
ID19155A (id) | 1996-12-13 | 1998-06-18 | Tanabe Seiyaku Co | Turunan-turunan piridin, pembuatannya dan intermediet untuk pembuatannya |
DE19727410A1 (de) | 1997-06-27 | 1999-01-07 | Hoechst Schering Agrevo Gmbh | 3-(5-Tetrazolylcarbonyl)-2-chinolone und diese enthaltende nutzpflanzenschützende Mittel |
US6514983B1 (en) | 1997-09-03 | 2003-02-04 | Guilford Pharmaceuticals Inc. | Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
TW430656B (en) | 1997-12-03 | 2001-04-21 | Dainippon Ink & Chemicals | Quinolinone derivative, method for preparing the same, and anti-allergic agent |
JP2002515490A (ja) | 1998-05-15 | 2002-05-28 | ギルフォード ファーマシューティカルズ インコーポレイテッド | Parp活性を抑制する縮合三環化合物 |
DE19921567A1 (de) | 1999-05-11 | 2000-11-16 | Basf Ag | Verwendung von Phthalazine-Derivaten |
JP2001302669A (ja) * | 2000-04-18 | 2001-10-31 | Meiji Seika Kaisha Ltd | 三環性フタラジノン誘導体 |
JP2002284699A (ja) | 2001-03-28 | 2002-10-03 | Sumitomo Pharmaceut Co Ltd | 視細胞変性疾患治療剤 |
AR036081A1 (es) | 2001-06-07 | 2004-08-11 | Smithkline Beecham Corp | Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos |
SE0102315D0 (sv) | 2001-06-28 | 2001-06-28 | Astrazeneca Ab | Compounds |
EP1477175B1 (en) | 2002-02-19 | 2011-04-27 | Ono Pharmaceutical Co., Ltd. | Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
EP1340819A1 (en) | 2002-02-28 | 2003-09-03 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Microsatellite markers |
GB0221443D0 (en) | 2002-09-16 | 2002-10-23 | Glaxo Group Ltd | Pyridine derivates |
EP1400244A1 (en) * | 2002-09-17 | 2004-03-24 | Warner-Lambert Company LLC | New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors |
WO2004043959A1 (ja) | 2002-11-12 | 2004-05-27 | Mochida Pharmaceutical Co., Ltd. | 新規parp阻害剤 |
JP4027406B2 (ja) | 2003-03-12 | 2007-12-26 | クドス ファーマシューティカルズ リミテッド | フタラジノン誘導体 |
EP1633362B1 (en) | 2003-05-28 | 2012-09-26 | Eisai Inc. | Compounds, methods and pharmaceutical compositions for inhibiting parp |
BRPI0507498A (pt) | 2004-02-18 | 2007-07-10 | Astrazeneca Ab | composto, composição farmacêutica, uso do composto, e, métodos para tratar distúrbios mediados por mglur 5 e para inibir ativação de receptores de mglur 5 |
GB0612971D0 (en) | 2006-06-30 | 2006-08-09 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
US8198448B2 (en) | 2006-07-14 | 2012-06-12 | Amgen Inc. | Fused heterocyclic derivatives and methods of use |
AU2008247102B2 (en) | 2007-05-03 | 2011-11-24 | Pfizer Limited | 2 -pyridine carboxamide derivatives as sodium channel modulators |
WO2010017850A1 (de) | 2008-08-12 | 2010-02-18 | Boehringer Ingelheim International Gmbh | Verfahren zur herstellung von cycloalkyl-substituierten piperazinverbindungen |
WO2009024190A1 (en) | 2007-08-22 | 2009-02-26 | 4Sc Ag | Indolopyridines as inhibitors of the kinesin spindle protein (eg5 ) |
MX2010003564A (es) * | 2007-10-03 | 2010-09-10 | Eisai Inc | Compuestos inhibidores de poli(adenosina-5'-difosfo-ribosa)polimer asa (parp), composiciones y metodos de uso. |
CN101998959B (zh) | 2008-02-06 | 2013-08-28 | 生物马林药物股份有限公司 | 聚(adp-核糖)聚合酶(parp)的苯并噁唑甲酰胺抑制剂 |
PL2326650T3 (pl) | 2008-08-06 | 2014-07-31 | Biomarin Pharm Inc | Dihydropirydoftalazynonowe inhibitory polimerazy poli-(ADP-rybozy) (PARP) |
CN102869258A (zh) | 2010-02-03 | 2013-01-09 | 生物马林药物股份有限公司 | 用于pten基因缺失相关疾病的治疗的聚(adp-核糖)聚合酶(parp)的二氢吡啶并酞嗪酮抑制剂 |
US20110190266A1 (en) | 2010-02-04 | 2011-08-04 | Daniel Chu | 5,6,6a,7,8,9-HEXAHYDRO-2H-PYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) |
HUE030794T2 (en) | 2010-02-08 | 2017-06-28 | Medivation Technologies Inc | Synthesis Processes of Dihydro-Pyrido-Phthalazinone Derivatives |
WO2011130661A1 (en) | 2010-04-16 | 2011-10-20 | Biomarin Pharmaceutical Inc. | Methods of using dihydropyridophthalazinone inhibitors of poly (adp-ribose)polymerase (parp) |
WO2011140009A1 (en) | 2010-05-04 | 2011-11-10 | Biomarin Pharmaceutical Inc. | Methods of using semi-synthetic glycopeptides as antibacterial agents |
TWI643858B (zh) | 2010-10-21 | 2018-12-11 | 美商梅迪維新技術有限責任公司 | 結晶型(8S,9R)-5-氟-8-(4-氟苯基)-9-(1-甲基-1H-1,2,4-三唑-5-基)-8,9-二氫-2H-吡啶并[4,3,2-de]呔-3(7H)-酮甲苯磺酸鹽 |
WO2012166151A1 (en) | 2011-06-03 | 2012-12-06 | Biomarin Pharmaceutical Inc. | Use of dihydropyridophthalazinone inhibitors of poly (adp-ribose) polymerase (parp) in the treatment of myelodysplastic syndrome (mds) and acute myeloid leukaemia (aml) |
WO2013028495A1 (en) | 2011-08-19 | 2013-02-28 | Biomarin Pharmaceutical Inc. | Dihydropyridophthalazinone inhibitors of poly (adp-ribose) polymerase (parp) for the treatment of multiple myeloma |
US20130053365A1 (en) | 2011-08-30 | 2013-02-28 | Biomarin Pharmaceutical, Inc. | Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) |
CN105916846A (zh) | 2013-11-07 | 2016-08-31 | 麦迪韦逊科技有限公司 | 用于合成经保护的n-烷基三唑甲醛的三唑中间体 |
EP3174855B1 (en) | 2014-07-31 | 2023-05-10 | Medivation Technologies LLC | Coformer salts of (2s,3s)-methyl 7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1h-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate and methods of preparing them |
-
2009
- 2009-07-27 PL PL09805360T patent/PL2326650T3/pl unknown
- 2009-07-27 CA CA2732797A patent/CA2732797C/en active Active
- 2009-07-27 JP JP2011522113A patent/JP5984389B2/ja active Active
- 2009-07-27 CN CN200980139634.2A patent/CN102171214B/zh active Active
- 2009-07-27 KR KR1020117005152A patent/KR101846029B1/ko active IP Right Grant
- 2009-07-27 DK DK09805360.6T patent/DK2326650T3/en active
- 2009-07-27 DK DK14154664.8T patent/DK2767537T3/da active
- 2009-07-27 SI SI200930881T patent/SI2326650T1/sl unknown
- 2009-07-27 MX MX2011001328A patent/MX2011001328A/es active IP Right Grant
- 2009-07-27 SG SG2013065719A patent/SG193842A1/en unknown
- 2009-07-27 SI SI200931668T patent/SI2767537T1/sl unknown
- 2009-07-27 BR BRPI0917119-3A patent/BRPI0917119B1/pt active IP Right Grant
- 2009-07-27 US US12/510,096 patent/US8012976B2/en active Active
- 2009-07-27 PL PL14154664T patent/PL2767537T3/pl unknown
- 2009-07-27 WO PCT/US2009/051879 patent/WO2010017055A2/en active Application Filing
- 2009-07-27 SG SG10201809895YA patent/SG10201809895YA/en unknown
- 2009-07-27 AU AU2009279944A patent/AU2009279944B2/en active Active
- 2009-07-27 ES ES14154664.8T patent/ES2625817T3/es active Active
- 2009-07-27 EP EP17161893.7A patent/EP3241832A1/en not_active Withdrawn
- 2009-07-27 EP EP09805360.6A patent/EP2326650B9/en active Active
- 2009-07-27 CN CN201410003342.9A patent/CN103896942A/zh active Pending
- 2009-07-27 PT PT98053606T patent/PT2326650E/pt unknown
- 2009-07-27 ES ES09805360.6T patent/ES2466565T3/es active Active
- 2009-07-27 PT PT141546648T patent/PT2767537T/pt unknown
- 2009-07-27 NZ NZ591166A patent/NZ591166A/xx unknown
- 2009-07-27 EP EP14154664.8A patent/EP2767537B1/en active Active
- 2009-07-27 HU HUE14154664A patent/HUE035295T2/en unknown
- 2009-07-27 CN CN201410640197.5A patent/CN104478875B/zh active Active
- 2009-07-27 LT LTEP14154664.8T patent/LT2767537T/lt unknown
- 2009-08-04 GB GB0913474A patent/GB2462361A/en not_active Withdrawn
- 2009-08-05 AR ARP090102999A patent/AR072970A1/es active IP Right Grant
- 2009-08-05 TW TW103106940A patent/TW201422617A/zh unknown
- 2009-08-05 TW TW098126400A patent/TWI448464B/zh active
-
2011
- 2011-02-03 IL IL211070A patent/IL211070A/en active Protection Beyond IP Right Term
- 2011-02-03 ZA ZA2011/00897A patent/ZA201100897B/en unknown
- 2011-03-31 US US13/077,785 patent/US8420650B2/en active Active
- 2011-11-04 HK HK11111926.3A patent/HK1157755A1/xx unknown
-
2013
- 2013-03-06 US US13/787,496 patent/US8999987B2/en active Active
-
2014
- 2014-03-28 CY CY20141100240T patent/CY1115022T1/el unknown
-
2015
- 2015-02-03 HK HK15101138.4A patent/HK1200813A1/xx unknown
- 2015-02-26 US US14/632,825 patent/US9820985B2/en active Active
- 2015-04-30 JP JP2015093417A patent/JP2015157843A/ja active Pending
-
2017
- 2017-05-31 CY CY20171100578T patent/CY1119218T1/el unknown
- 2017-06-29 HR HRP20170982TT patent/HRP20170982T1/hr unknown
- 2017-07-27 JP JP2017145036A patent/JP2018012698A/ja active Pending
- 2017-09-28 US US15/719,534 patent/US10543209B2/en active Active
-
2019
- 2019-11-28 CY CY2019044C patent/CY2019044I2/el unknown
- 2019-11-28 NO NO2019042C patent/NO2019042I1/no unknown
- 2019-12-03 FR FR19C1071C patent/FR19C1071I2/fr active Active
- 2019-12-05 LT LTPA2019522C patent/LTC2767537I2/lt unknown
- 2019-12-11 NL NL301021C patent/NL301021I2/nl unknown
- 2019-12-11 LU LU00140C patent/LUC00140I2/fr unknown
- 2019-12-13 US US16/714,474 patent/US10780088B2/en active Active
- 2019-12-19 HU HUS1900053C patent/HUS1900053I1/hu unknown
-
2020
- 2020-08-21 US US17/000,271 patent/US11364241B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2018012698A5 (ja) | ||
JP2018100276A5 (ja) | ||
TWD173653S (zh) | 輪圈 | |
JP2017137500A5 (ja) | ||
WO2018081502A8 (en) | Synthetic bacteriophages and bacteriophage compositions | |
JP2018533683A5 (ja) | ||
TWD173737S (zh) | 肌肉鍛鍊機器 | |
JP2015186128A5 (ja) | ||
JP2017211493A5 (ja) | 露光装置、および、物品の製造方法 | |
WO2015191945A3 (en) | Solid state forms of sofosbuvir | |
IL262747A (en) | Anti-kv1.3 antibodies, methods for their production and use | |
JP2016540019A5 (ja) | ||
JP2015173751A5 (ja) | ||
JP2016540026A5 (ja) | ||
JP2017537928A5 (ja) | ||
JP2017197541A5 (ja) | ||
JP2016038993A5 (ja) | ||
JP2018519528A5 (ja) | ||
HK1246215A1 (zh) | 去細胞角膜及其製備方法和用途 | |
JP2016047837A5 (ja) | ||
JP2015005289A5 (ja) | ||
JP2016011847A5 (ja) | ||
TH184330B (th) | เข็มกลัด | |
TH184332B (th) | เข็มกลัด | |
TH184340B (th) | เข็มกลัด |